CANDEL 1.4.0

Generated by Alzabo

Entities

Reference

cell-typeRepresents a cell type entity, typically using the Cell Ontology (CL) for reference.
chr-acc-regA chromatin accessible region, specified by genomic coordinates.
clinical-trialClinical trial registration and description, referenced with NCT number and aliases.
cnvCopy Number Variation segment, referencing genomic location and contained genes.
comorbidityRepresents a comorbid condition or disease present alongside the primary diagnosis.
drugA pharmaceutical compound, drug, or active moiety.
epitopeA protein region (epitope) used, e.g., as a marker or antibody target.
gdc-anatomic-siteAn anatomic site as defined in the Genomics Data Commons (GDC) vocabulary.
geneA human gene, referenced via HGNC symbol and cross-references to major databases.
gene-productRepresents a specific gene product such as an mRNA or protein isoform.
genomic-coordinateIdentifies a specific contiguous genomic region on a particular assembly.
meddra-diseaseA disease definition as per the MedDRA classification vocabulary.
nanostring-signatureA reference to a named nanostring gene expression signature.
neo-antigenA predicted or validated neo-antigen peptide arising from a variant.
proteinA specific protein including synonyms and cross-references, typically UniProt-based.
so-sequence-featureDefines a functional sequence feature as per the Sequence Ontology.
variantDescribes a genomic variant, with associated consequences, frequencies, and links to features.

Experimental

adverse-eventAn adverse event (AE) report for a subject, as observed in a clinical study.
assayAn experimental assay (e.g., RNA-seq, flow cytometry) performed within a dataset.
atac-peakA chromatin peak called from ATAC-seq experiments, with location and score attributes.
cell-populationA defined population of cells, e.g., as determined by phenotype or clustering.
clinical-observationDiscrete clinical data point measured/recorded for a subject (e.g., BMI, survival, tumor burden).
clinical-observation-setA group of clinical observations, typically for a single subject or within a cohort.
datasetA complete dataset record encompassing all measurements, samples, and treatments for a study.
drug-regimenA specification of a single drug’s use within a treatment regimen.
measurementQuantitative or qualitative measurement performed on biological samples.
measurement-matrixRepresents a matrix or file of measurement values, e.g., an expression matrix.
measurement-setA collection that groups related measurement records, typically linked via an assay.
otuAn Operational Taxonomic Unit (OTU), representing a microbial grouping for metagenomics.
sampleA biological specimen sample, ranging from solid tissue to biofluids.
single-cellEntity representing a single cell, with image coordinates as may be found in microscopy data.
study-dayA day relative to a defined study reference event (e.g., enrollment).
subjectA participant (patient or animal) in a study or clinical dataset.
tcrA unique T-cell receptor (TCR) sequence entity, optionally with both alpha and beta chains.
therapyA record representing a therapy administered to a subject, including regimen and evaluability.
timepointA discrete timepoint in a study or therapy, e.g., baseline or post-treatment.
treatment-regimenSpecification of a full treatment plan or course, including constituent drugs and timing.

Enums

adverse-event.ae-causalityAE is causally related to drug/therapy., AE is not causally related to drug/therapy.
adverse-event.ctcae-gradeGrade 1 (mild)., Grade 2 (moderate)., Grade 3 (severe)....
analysis.typeDifferential expression analysis., Differential methylation analysis., Pathway enrichment analysis....
assay.technologyQuantitative PCR., Whole Genome Sequencing., DNA sequencing, unspecified type....
clinical-observation.borPartial Response., Unconfirmed Partial Response., Confirmed Partial Response....
clinical-observation.disease-stageStage III D., Stage I C., Stage I A....
clinical-observation.event-reasonSubject withdrew from study., Event status unknown., Censored for unknown reason....
clinical-observation.ir-recistImmune-related complete response., Immune-related partial response., Immune-related stable disease....
clinical-observation.ranoPartial response., Stable disease., Complete response....
clinical-observation.recistPartial response., Progressive disease., Stable disease....
gene.hgnc-locus-groupProtein-coding gene., Non-coding RNA gene., Pseudogene....
genomic-coordinate.assemblyGenome Reference Consortium Human (GRCh37)., Genome Reference Consortium Human (GRCh38)., NCBI build 36....
measurement.cnv-callCopy number amplified segment., Copy number neutral segment., Copy number reduction segment.
measurement.msi-statusMicrosatellite stable (MSS)., Microsatellite instability – low (MSI-L)., Microsatellite instability – high (MSI-H).
moleculeGene molecule., Protein molecule.
sample.containerOMNIgene Gut fecal sample tube., Sodium citrate blood collection tube., PAXgene Blood DNA tube....
sample.lateralitySample from both sides (bilateral)., Sample from left side., Sample from right side....
sample.specimenFlash frozen tissue specimen., In vitro cell line., Serum specimen....
sample.tissue-acquisition-methodSample obtained by full surgical resection., Sample obtained by surgical biopsy., Ultrasound-guided biopsy....
sample.typeTumor tissue sample., Normal tissue sample., Abnormal (pathologic) non-tumor sample....
study-day.reference-eventDay of enrollment in the study., Day of diagnosis., Date of surgery.
subject.cause-of-deathDeath related to cancer., Death unrelated to cancer.
subject.ethnicitySubject identifies as hispanic or latino/a., Subject identifies as not hispanic or latino/a.
subject.raceWhite/Caucasian race., American Indian or Alaska Native., African-American or Black....
subject.sexFemale subject., Male subject., Sex unknown or not reported.
subject.smokerFormer smoker., Current smoker., Never smoker.
therapy.previousNo prior therapy (treatment-naive)., Prior radiation therapy., Prior anti-PD-1 or anti-PD-L1 therapy....
timepoint.typeBaseline/pretreatment timepoint., Tumor assessment timepoint., Surgical intervention timepoint....
treatment-regimen.settingNeoadjuvant (pre-surgical) setting., Adjuvant (post-surgical) setting., Palliative care (symptom management).
variant.classification5' flanking sequence., 5' untranslated region., Splice site mutation....
variant.featureA transcript region., A regulatory feature region., A nucleotide or protein motif.
variant.impactHigh predicted impact on function., Moderate impact., Low impact....
variant.typeInsertion., Deletion., Single Nucleotide Polymorphism....